DrugPatentWatch Database Preview
Profile for Israel Patent: 213289
US Patent Family Members and Approved Drugs for Israel Patent: 213289
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Dec 28, 2030 | Sanofi-aventis Us | ADLYXIN | lixisenatide |
➤ Try a Free Trial | Dec 28, 2030 | Sanofi-aventis Us | ADLYXIN | lixisenatide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |